DE602004022523D1 - Verwendung von Emulsionen zur intra- und periocularen Injection - Google Patents

Verwendung von Emulsionen zur intra- und periocularen Injection

Info

Publication number
DE602004022523D1
DE602004022523D1 DE602004022523T DE602004022523T DE602004022523D1 DE 602004022523 D1 DE602004022523 D1 DE 602004022523D1 DE 602004022523 T DE602004022523 T DE 602004022523T DE 602004022523 T DE602004022523 T DE 602004022523T DE 602004022523 D1 DE602004022523 D1 DE 602004022523D1
Authority
DE
Germany
Prior art keywords
intra
emulsions
periocular injection
periocular
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004022523T
Other languages
English (en)
Inventor
Laura Rabinovich-Guilatt
Kozak Yvonne De
Catherine Dubernet
Gregory Lambert
Simon Benita
Patrick Couvreur
Francine Behar-Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novagali SA
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Novagali SA
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali SA, Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Novagali SA
Publication of DE602004022523D1 publication Critical patent/DE602004022523D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
DE602004022523T 2004-07-02 2004-07-02 Verwendung von Emulsionen zur intra- und periocularen Injection Active DE602004022523D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04291684A EP1611879B1 (de) 2004-07-02 2004-07-02 Verwendung von Emulsionen zur intra- und periocularen Injection

Publications (1)

Publication Number Publication Date
DE602004022523D1 true DE602004022523D1 (de) 2009-09-24

Family

ID=34931219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022523T Active DE602004022523D1 (de) 2004-07-02 2004-07-02 Verwendung von Emulsionen zur intra- und periocularen Injection

Country Status (4)

Country Link
US (1) US20060002963A1 (de)
EP (1) EP1611879B1 (de)
AT (1) ATE439123T1 (de)
DE (1) DE602004022523D1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809237B1 (de) 2004-11-09 2008-12-31 Novagali Pharma SA Ophthalmische öl-in-wasser-emulsion mit stabilem positivem zeta-potential
ES2314354T3 (es) 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
DK2564843T3 (en) 2005-06-01 2019-03-11 Bioelectron Tech Corp Redox-active therapeutics for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers
US20070225217A1 (en) 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
CN100435843C (zh) * 2006-04-21 2008-11-26 北京国丹药物技术开发有限公司 一种胸腺五肽与干扰素的组合物
US20070281914A1 (en) * 2006-06-01 2007-12-06 Laura Rabinovich-Guilatt Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101130058B (zh) * 2006-08-23 2011-10-05 华北制药集团新药研究开发有限责任公司 一种环孢菌素a眼用乳剂及其制备方法
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
EP2286224A4 (de) * 2008-05-05 2012-04-25 Univ Winthrop Hospital Verfahren zur verbesserung des kardiovaskulären risikoprofils von cox-hemmern
EP2306978A2 (de) 2008-06-06 2011-04-13 Mirna Therapeutics, Inc. Zusammensetzungen zur abgabe von rnai-mitteln in vivo
JP2012502064A (ja) 2008-09-10 2012-01-26 エジソン ファーマシューティカルズ， インコーポレイテッド 酸化還元活性治療剤を用いての広汎性発達障害の処置
JP5890182B2 (ja) 2009-02-12 2016-03-22 インセプト エルエルシー ヒドロゲルプラグによる薬物送達
HUE037574T2 (hu) 2009-04-28 2018-09-28 Bioelectron Tech Corp Leber-féle örökletes optikus neuropátia és domináns optikus atrofia kezelése tokotrienol kinonokkal
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
CA2778181A1 (en) 2009-10-26 2011-05-05 Thomas Julius Borody Therapy for enteric infections
TW201138782A (en) * 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
WO2012138003A1 (ko) * 2011-04-08 2012-10-11 경북대학교 산학협력단 탈황산화된 헤파린-담즙산 유도체의 염증성 질환의 예방 및 치료 용도
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
EP3613413A1 (de) 2011-12-05 2020-02-26 Incept, LLC Medizinische organogelprozesse und -zusammensetzungen
CA2893767C (en) 2012-12-05 2022-11-08 Novartis Ag Compositions and methods for antibodies targeting epo
RU2539161C2 (ru) * 2012-12-17 2015-01-10 Танзиля Сыонгалиевна Корнилова Способ лечения герпесвирусного поражения внутренних оболочек глаза
EP3791883B1 (de) 2014-07-30 2023-10-25 Massachusetts Eye & Ear Infirmary Methotrexat zur proliferativen vitreoretinopathie
JP2018525389A (ja) 2015-08-12 2018-09-06 ノバルティス アーゲー 眼障害を治療する方法
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US11040019B2 (en) 2016-08-19 2021-06-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
PT3500255T (pt) 2016-08-19 2023-01-10 Orasis Pharmaceuticals Ltd Composições farmacêuticas oftálmicas e utilizações relacionadas com estas
FR3057774A1 (fr) * 2016-10-21 2018-04-27 Museum National D'histoire Naturelle Derives de la purine pour leur utilisation dans le traitement ou la prevention de maladies dues a une mutation non-sens
CN106963725A (zh) * 2017-04-19 2017-07-21 赵艳霞 一种地塞米松纳米凝胶及其制备方法
CN113648421A (zh) * 2021-08-19 2021-11-16 中山大学中山眼科中心 磺酰脲类药物在制备治疗葡萄膜炎的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
DE69328368T2 (de) * 1992-08-28 2000-08-10 Pharmos Corp Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
WO1995003009A1 (en) * 1993-07-22 1995-02-02 Oculex Pharmaceuticals, Inc. Method of treatment of macular degeneration
US5770589A (en) * 1993-07-27 1998-06-23 The University Of Sydney Treatment of macular degeneration
EP1020194A4 (de) * 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd Öl/wasser emulsion zusammenstellungen
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
ATE468107T1 (de) * 2001-11-01 2010-06-15 Yissum Res Dev Co Verfahren und zusammensetzung zur behandlung von trockenen augen

Also Published As

Publication number Publication date
EP1611879B1 (de) 2009-08-12
EP1611879A1 (de) 2006-01-04
US20060002963A1 (en) 2006-01-05
ATE439123T1 (de) 2009-08-15

Similar Documents

Publication Publication Date Title
ATE439123T1 (de) Verwendung von emulsionen zur intra- und periocularen injection
ATE498395T1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
CY1118179T1 (el) Φαρμακευτικη συνθεση
ATE401874T1 (de) Verabreichung von capsaicinoiden
ATE555777T1 (de) Pharmazeutische zusammensetzung
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
EA200401252A1 (ru) Микрочастицы лекарственных веществ
BRPI0518460A2 (pt) mÉtodo para tratar emergÊncia alÉrgica em um paciente, dispositivo de distribuiÇço de droga contendo uma soluÇço de epinefrina, e, kit para tratar uma emergÊncia alÉrgia'
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
CY1109070T1 (el) Διαδερμικη μορφη δοσολογιας περιλαμβανουσα ενα δραστικο παραγοντα και ενα αλας και μια μορφη ελευθερης βασεως ενος ανταγωνιστη
BRPI0603073A (pt) método para distribuição de fármacos para tecido sob propulsão de microjatos
BRPI0519171A2 (pt) dispositivo de administraÇço de medicamento oftÁlmico
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
TR201905174T4 (tr) Lokal analjezi, lokal anestezi veya sinir blokajı sağlamak için bir ilaç iletim cihazı.
BRPI0508596A (pt) combinação compreendendo ligante alfa-2-delta
ATE539747T1 (de) Verfahren und medikamente zur verabreichung von ibuprofen
HRP20080178T3 (en) Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
SE0301663D0 (sv) Analysmetod för infusionsläkemedel
CR9200A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
DE60135390D1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
WO2006003519A3 (en) Use of emulsions for intra: and periocular injection

Legal Events

Date Code Title Description
8364 No opposition during term of opposition